|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Diagnostic Imaging | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Glioblastoma | |||||
| 3 | More general conditions related to this trial | ||||
| Astrocytoma | |||||
| Glioma | |||||
| Neoplasms | |||||
| Neoplasms by Histologic Type | |||||
| Neoplasms, Germ Cell and Embryonal | |||||
| Neoplasms, Glandular and Epithelial | |||||
| Neoplasms, Nerve Tissue | |||||
| Neoplasms, Neuroepithelial | |||||
| Neuroectodermal Tumors | |||||
| 4 | Interventions listed in this trial | ||||
| Ferumoxytol | |||||
| 5 | Sponsors listed in this trial | ||||
| Oregon Health and Science University | |||||
| National Cancer Institute (NCI) | |||||